Global Bioabsorbable Orthopedic Implant Market Size, Share, and COVID-19 Impact Analysis, By Application (Tissue Repair, Bone Fixation, Cartilage Repair, and Orthopedic Surgery), By End Use (Hospitals, Ambulatory Surgical Centers, and Specialty Clinics), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Bioabsorbable Orthopedic Implant Market Insights Forecasts to 2035

• The Global Bioabsorbable Orthopedic Implant Market Size Was Estimated at USD 1.15 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 14.60% from 2025 to 2035
• The Worldwide Bioabsorbable Orthopedic Implant Market Size is Expected to Reach USD 5.15 Billion by 2035
• Asia Pacific is Expected to Grow the Fastest during the forecast period.

The Global Bioabsorbable Orthopedic Implant Market Size was worth around USD 1.15 Billion in 2024 and is predicted to grow to around USD 5.15 Billion by 2035 with a compound annual growth rate (CAGR) of 14.60% from 2025 to 2035. The growing prevalence of orthopedic conditions, medical technology advancements, as well as the growing biomaterials awareness, are driving the bioabsorbable orthopedic implant market globally.

Market Overview

The bioabsorbable orthopedic implant market is the market for medical devices, primarily used in surgical procedures, that are designed to be absorbed by the body over time, eliminating the need for removal surgeries. Bioabsorbable implants are popularly used in orthopaedics, as they are essential in treating musculoskeletal disorders and aid in stabilizing and strengthening weak bones and joints. The market is primarily driven by the demand for medical devices addressing age-related health issues, with the global increase in the aging population. Ongoing advancements in material science are revolutionizing the bioabsorbable implant market. Further, innovative bioabsorbable implants that exhibit enhanced mechanical properties and biocompatibility are being developed by researchers and manufacturers. Further, an innovation in material science has enabled the customization of degradation rates for bioabsorbable implants. The growing prevalence of the elderly population, along with an increasing need for robotics, is escalating the new growth opportunities in the bioabsorbable orthopaedic implant market.

Report Coverage

This research report categorizes the bioabsorbable orthopedic implant market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the bioabsorbable orthopedic implant market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the bioabsorbable orthopedic implant market.

Driving Factors

The growing prevalence of orthopedic conditions is responsible for driving the bioabsorbable orthopedic implant market. Orthopaedic implants are popularly used for treating musculoskeletal disorders as they aid in stabilizing and strengthening weak bones and joints. It was estimated that approximately 1.71 billion people have musculoskeletal conditions, which is the leading contributor to disability worldwide. Medical technology advancements in bioabsorbable orthopaedic implants, driven by the need for less invasive procedures and improved patient outcomes, are propelling the market growth.

Restraining Factors

The use of high-end technologies is challenging the bioabsorbable orthopedic implant market. Further, the increased cost required for system maintenance and installation is restraining the market growth. The side effects associated with the use of these devices may be responsible for hampering the market demand.

Market Segmentation

The bioabsorbable orthopedic implant market share is classified into application and end use.

• The bone fixation segment dominated the market with a major share in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the application, the bioabsorbable orthopedic implant market is divided into tissue repair, bone fixation, cartilage repair, and orthopedic surgery. Among these, the bone fixation segment dominated the market with a major share in 2024 and is projected to grow at a substantial CAGR during the forecast period. Bioabsorbable implants offer a minimally invasive approach for bone fixation, gradually dissolving and being absorbed by the body as the bone heals, eliminating the need for a second surgery to remove the implant, reducing the risk of complications associated with retained hardware, and promoting better tissue integration. Thus, the fundamental role of bioabsorbable orthopaedic implants for orthopaedic repairs is driving the market in the bone fixation segment.

• The hospitals segment dominated the bioabsorbable orthopedic implant market in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the end use, the bioabsorbable orthopedic implant market is divided into hospitals, ambulatory surgical centers, and specialty clinics. Among these, the hospitals segment dominated the bioabsorbable orthopedic implant market in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The orthopaedic department in hospitals provides a range of services, from minimally invasive procedures to complex surgeries that aim to restore mobility and reduce pain. The presence of comprehensive resources, increased patient volumes, and capacity for complex surgeries in hospitals is driving the market growth in the hospitals segment.

Regional Segment Analysis of the Bioabsorbable Orthopedic Implant Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the bioabsorbable orthopedic implant market over the predicted timeframe.

North America is anticipated to hold the largest share of the bioabsorbable orthopedic implant market over the predicted timeframe. The continuous innovations of implants and demand for less invasive and cost-effective joint replacement surgery are driving the market growth for bioabsorbable orthopaedic implant. Further, the region’s advanced healthcare infrastructure, along with an increased prevalence of orthopaedic conditions, is propelling the market. The presence of key market players and comprehensive reimbursement coverage is also bolstering the market for bioabsorbable orthopedic implant.

Asia Pacific is expected to grow at a rapid CAGR in the bioabsorbable orthopedic implant market during the forecast period. An increasing number of accidents and sports injuries, driving the demand for internal fixation surgery, is anticipated to drive the market demand. Further, the rising spending on healthcare, as well as an increased prevalence of chronic disease, are significantly propelling the bioabsorbable orthopaedic implant market. In addition, the healthcare infrastructure development and the booming medical tourism industry are also promoting the market.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the bioabsorbable orthopedic implant market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Integra LifeSciences
• Johnson and Johnson
• Corentec
• GRAFITEC
• Braun
• Smith and Nephew
• Stryker
• Tissue Regenix
• Medtronic
• MediNova
• DePuy Synthes
• KLS Martin
• Zimmer Biomet
• Everost
• Bioretec
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Recent Development

• In April 2025, CG MedTech, a Korean-based orthopedic implant company specializing in magnesium alloy technology, entered full-scale development of a next-generation bioresorbable vascular stent that naturally degrades in the body after fulfilling its intended function.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the bioabsorbable orthopedic implant market based on the below-mentioned segments: 

Global Bioabsorbable Orthopedic Implant Market, By Application

• Tissue Repair
• Bone Fixation
• Cartilage Repair
• Orthopedic Surgery

Global Bioabsorbable Orthopedic Implant Market, By End Use

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

Global Bioabsorbable Orthopedic Implant Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa